Us News

Cohen’s scrutiny comes as GameStop pursues a $56 billion takeover promising major savings and leadership changes.

Wall Street is now focused on Monday’s Q1 earnings report, with analysts expecting revenue of $40 million and a narrower quarterly loss.

The company plans to submit its biologics license application (BLA) by September.

Eli Lilly’s oral obesity pill Foundayo reportedly generated 7,335 prescriptions in its fourth week on the market.

On Monday, AbCellera will release its financial results alongside interim early-stage data for its lead internal candidate ABCL635.

The firm reported total assets of $2.2 billion for the first quarter ended March.

Though the firm called the meeting ‘constructive’, investors seem more focused on the agency’s reservations about the laromestrocel trial’s design and its potential to support approval.

Cerebras could be the largest IPO in the U.S. so far this year.

Moderna’s ongoing hantavirus vaccine efforts, reported by Bloomberg, coincide with heightened public attention on a rare outbreak linked to the Dutch-flagged MV Hondius.

Honeywell’s Quantinnum files for IPO.

NHTSA said it will assess technical and operational factors, existing safeguards, and any mitigating actions taken by Avride as part of the probe.

"Go out and buy a Dell! They're great," said Trump at a White House event.

The Wall Street Journal reported on the plans on Friday, citing people familiar with the matter, while noting that other top administration officials believe Makary is struggling to manage his agency.

The financing would be one of the largest ever private credit deals.

AIM ImmunoTech announced an agreement with certain accredited investors to exercise outstanding warrants for $0.48 per share to raise $4.2 million in gross proceeds.

Uber Technologies, Lucid Group, and Nuro announced a strategic partnership in July 2025 to launch a premium global robotaxi program exclusively on the Uber ride-hailing platform.

The company signed a non-binding memorandum of understanding with White Group to help secure funding for its planned automated battery production facility in Texas.

Alfred scooped up 270,000 shares of Opendoor Technologies at an average price of $4.89 on Friday.

British billionaire Chris Hohn’s hedge fund TCI cut its position in Microsoft from 10% to 1%.

Antelope Enterprises said it triggered what it called the "Genius Recycler" mechanism, which demonstrated the firm’s ability to allocate 50% of realized crypto gains to shareholder returns.

Wedbush remains bullish on INOD and raised its price target following the firm’s stellar first-quarter results.

Traws Pharma, which develops antiviral drugs, said it plans to advance potential clinical candidates for the treatment of hantavirus infections.

Applied Optoelectronics CEO stated that the company expects a strong volume ramp of its 800G products beginning in the second quarter and projects continued revenue growth throughout 2026.

Several analysts cheered the company’s impressive cloud revenue growth and raised their price targets.

Artiva announced a $300 million public offering to support the development of its autoimmune disease therapies, but at a 9% discount per share compared to Thursday’s closing price.

Trade Desk provided lower-than-expected Q2 guidance, prompting a wave of downgrades and price cuts on Wall Street, with analysts hinting at competitive pressures and macro headwinds.

Citizens raised its price target on Rocket Lab to $95 from $85 and maintained an ‘Outperform’ rating after the company posted a record-breaking first-quarter revenue.

NuScale Power Corp, Oklo Inc, and Nano Nuclear Energy Inc have been in the spotlight for their partnerships with hyperscalers to satiate their need for clean energy to fuel AI infrastructure.

Analysts are skeptical about the company’s path to reaccelerating growth following its first-quarter results.

GD Culture Group received a preliminary take-private offer earlier this week that represented a roughly 169% premium to its prior closing price.

The travel company expects 2026 revenue of between $15.6 billion and $16 billion.

TD Cowen and Baird lowered McDonald’s price targets following the first-quarter earnings.

One influencer warned that shareholders could face “permanent economic leakage” if Tesla ends up paying SpaceXAI for AI services.

Innodata increased its full-year 2026 revenue growth forecast to around 40% or more.

Traders are also watching the FDA review of ImmunityBio’s resubmitted Anktiva plus BCG filing for non-muscle invasive bladder cancer with papillary tumors.

A hantavirus outbreak aboard a cruise ship has resulted in three deaths and raised global health concerns.

Inovio is the most direct hantavirus play based on earlier DNA vaccine studies targeting Andes, Hantaan, and Puumala strains.

Datadog is also on track to be the top gainer this week on the Nasdaq 100 and the second-best performer on the S&P 500.

Wall Street expects another loss-making quarter, with Koyfin estimates projecting EPS loss to widen to $0.06 from $0.05.

Weak earnings, lower outlooks, and rising costs show middle-class consumers are spending less on food and fitness services broadly.

The latest move by Amazon adds pressure on Hims, which already offers branded GLP-1 drugs including Wegovy, Ozempic and Zepbound.

The company forecast Q2 revenue of at least $750 million, below analyst estimates of $770.41 million.

Capricor is seeking court approval to pursue an alternative commercialization path for Deramiocel and wants parts of the agreement terminated.

Lyft reported mixed first-quarter results and clocked double-digit growth in revenue while net income fell below estimates.

Cloudflare laid off one-fifth of its total employees amid a shift to an agentic AI operating model.

Rocket Lab said that a confidential customer booked five dedicated missions on its Neutron rocket and three dedicated missions on its small -sat Electron rocket, spanning 2026–2029.

Weaker crypto markets dragged down Coinbase’s core trading business.

Gilead slashed its full-year earnings outlook primarily due to anticipated charges and financing costs from its recent acquisitions of Arcellx, Ouro Medicines, and Tubulis.

SoundHound AI’s Q1 revenue jumps 52%, beating expectations.

Under the deal, NVIDIA will receive a five-year warrant to purchase up to 30 million IREN shares at $70 per share, while IREN will deploy massive clusters of NVIDIA’s latest GPUs.